Fresenius SE EBITDA Margin 2016-2024 | FSNUY

Fresenius SE ebitda margin for the quarter ending June 30, 2024 was 10.17%.

  • Fresenius SE average ebitda margin for 2023 was 13.06%, a 21.61% decline from 2022.
  • Fresenius SE average ebitda margin for 2022 was 16.66%, a 10.62% decline from 2021.
  • Fresenius SE average ebitda margin for 2021 was 18.64%, a 6.1% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Fresenius SE EBITDA Margin 2016-2024 | FSNUY

  • Fresenius SE average ebitda margin for 2023 was 13.06%, a 21.61% decline from 2022.
  • Fresenius SE average ebitda margin for 2022 was 16.66%, a 10.62% decline from 2021.
  • Fresenius SE average ebitda margin for 2021 was 18.64%, a 6.1% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$17.4B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.3B
Elanco Animal Health (ELAN)$7.2B
RadNet (RDNT)$5.3B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.9B
Astrana Health (ASTH)$2.9B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$227M
Daxor (DXR)$45M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$13M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M